Kecheng Zhou

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Venues

Oncogenesis

Cell death & disease

Cancer science

Cancer biology & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ruyu Yan, Dan Liu, Hongjuan Guo, Minxia Liu, Dongjin Lv, Benny Björkblom, Mingsong Wu, Hongtao Yu, Hao Leng, Bingxiao Lu, Yuxiang Li, Miaomiao Gao, Tomas Blom, Kecheng Zhou
LAPTM4B counteracts ferroptosis via suppressing the ubiquitin-proteasome degradation of SLC7A11 in non-small cell lung cancer. Cell death & disease 15 (6) (2024)
Ruyu Yan, Dan Liu, Hongjuan Guo, Minxia Liu, Dongjin Lv, Benny Björkblom, Mingsong Wu, Hongtao Yu, Hao Leng, Bingxiao Lu, Yuxiang Li, Miaomiao Gao, Tomas Blom, Kecheng Zhou
LAPTM4B counteracts ferroptosis via suppressing the ubiquitin-proteasome degradation of SLC7A11 in non-small cell lung cancer. Cell death & disease 15 (6) (2024)
Ruyu Yan, Dan Liu, Hongjuan Guo, Minxia Liu, Dongjin Lv, Benny Björkblom, Mingsong Wu, Hongtao Yu, Hao Leng, Bingxiao Lu, Yuxiang Li, Miaomiao Gao, Tomas Blom, Kecheng Zhou
LAPTM4B counteracts ferroptosis via suppressing the ubiquitin-proteasome degradation of SLC7A11 in non-small cell lung cancer. Cell death & disease 15 (6) (2024)
Wei Zheng, Shujiang Ye, Bin Liu, Dan Liu, Ruyu Yan, Hongjuan Guo, Hongtao Yu, Xudong Hu, Huaiming Zhao, Kecheng Zhou, Guangyuan Li
Crosstalk between GBP2 and M2 macrophage promotes the ccRCC progression. Cancer science (2024)
Ruyu Yan, Dan Liu, Junjie Wang, Minxia Liu, Hongjuan Guo, Jing Bai, Shuo Yang, Jun Chang, Zhihong Yao, Zuozhang Yang, Tomas Blom, Kecheng Zhou
miR-137-LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma. Oncogenesis 12 (1) (2023)
Ruyu Yan, Dan Liu, Junjie Wang, Minxia Liu, Hongjuan Guo, Jing Bai, Shuo Yang, Jun Chang, Zhihong Yao, Zuozhang Yang, Tomas Blom, Kecheng Zhou
miR-137-LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma. Oncogenesis 12 (1) (2023)
Shuo Yang, Ping Zhou, Lelei Zhang, Xiangpeng Xie, Yuanyi Zhang, Kaida Bo, Jing Xue, Wei Zhang, Faxue Liao, Pengfei Xu, Yong Hu, Ruyu Yan, Dan Liu, Jun Chang, Kecheng Zhou
VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma. Cancer biology & therapy 24 (1) (2023)
Ruyu Yan, Dan Liu, Junjie Wang, Minxia Liu, Hongjuan Guo, Jing Bai, Shuo Yang, Jun Chang, Zhihong Yao, Zuozhang Yang, Tomas Blom, Kecheng Zhou
miR-137-LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma. Oncogenesis 12 (1) (2023)
Ruyu Yan, Dan Liu, Junjie Wang, Minxia Liu, Hongjuan Guo, Jing Bai, Shuo Yang, Jun Chang, Zhihong Yao, Zuozhang Yang, Tomas Blom, Kecheng Zhou
miR-137-LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma. Oncogenesis 12 (1) (2023)
Minxia Liu, Ruyu Yan, Junjie Wang, Zhihong Yao, Xinyu Fan, Kecheng Zhou
LAPTM4B-35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics. Cancer science 113 (6) (2022)

Kecheng Zhou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kecheng Zhou